Former Novo CEO Lars Rebien appointed executive chair at Ferring
Lars Rebien Sørensen, the former long-standing CEO of Novo Nordisk, joined Ferring Pharmaceuticals as chair of the board in summer last year, and has now been appointed its executive chair, an amalgamation of a chief executive and chair position, although he retains most of his chair duties. The news comes with a record-breaking annual report from the company.
by albert rønning-andersson, translated by daniel pedersen
The chair of the Novo Nordisk Foundation, Lars Rebien Sørensen, who stood at the helm of Novo Nordisk for many years, has been appointed Executive Chairman at Ferring Pharmaceuticals, a company press release has announced.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
